Neuroprogression

Neuroprogression denotes the gradual deterioration of symptoms and cognitive functions seen in various neurological disorders like Alzheimer's, Parkinson's, and multiple sclerosis (MS). It encapsulates the evolving structural and functional alterations within the brain, ultimately resulting in escalating disability and impairment in daily life. This phenomenon encompasses the progressive accumulation of neuronal damage, inflammation, and the loss of neural connections. In Alzheimer's, neuroprogression entails the progressive accumulation of amyloid plaques and tau protein tangles, leading to nerve cell degeneration and cognitive decline. Similarly, Parkinson's disease manifests as the gradual loss of dopamine-producing neurons in the substantia nigra, worsening motor symptoms like tremors and stiffness. In MS, immune attacks on the myelin sheath lead to scar tissue formation and progressive neurological dysfunction, including muscle weakness and coordination problems. Understanding neuroprogression is pivotal for devising effective treatments to slow or halt disease progression. Researchers explore various strategies, from targeted medications to lifestyle interventions and neurorehabilitation techniques, to mitigate neuroprogressive processes and enhance patients' quality of life. Early diagnosis, ongoing monitoring, and multidisciplinary care are vital for managing the complex needs of individuals with progressive neurological conditions.